Mucopolysaccharidosis type 6, rapidly progressing

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Mucopolysaccharidosis type 6, rapidly progressing.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

NAGLAZYME

BioMarin Pharmaceutical Inc.

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

NAGLAZYME

(GALSULFASE)Orphan drugstandard

BioMarin Pharmaceutical Inc.

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Mucopolysaccharidosis type 6, rapidly progressing.
Search all trials →
Search clinical trials for Mucopolysaccharidosis type 6, rapidly progressing

Recent News & Research

No recent news articles indexed yet for Mucopolysaccharidosis type 6, rapidly progressing.
Search PubMed for Mucopolysaccharidosis type 6, rapidly progressing

Browse all Mucopolysaccharidosis type 6, rapidly progressing news →

Specialist Network

No specialists currently listed for Mucopolysaccharidosis type 6, rapidly progressing.

View all Mucopolysaccharidosis type 6, rapidly progressing specialists →

Quick Actions